Although direct clinical evidence linking SE enrichment or BRD4 genomic occupancy to radioresistance in HNSCC patients remains limited, these epigenomic observations collectively support a mechanistic framework in which BRD4-dependent SE function contributes to cellular responses to therapeutic stress, including ionizing radiation. The gene discussed is BRD4; the disease is head and neck squamous cell carcinoma.